Topic Intelligence: pharmaceuticals

Advanced Micro Devices (AMD) and ARM Holdings are surging as hyperscalers—cloud providers and AI infrastructure companies—place massive orders for CPUs to power AI training and inference workloads. UBS analysts project further upside for both stocks as demand for custom and general-purpose processors accelerates.

AMD and ARM are capturing share from Intel in data center and edge AI markets. The sustained demand from hyperscalers (Amazon, Google, Meta, Microsoft) validates a multi-chip architecture strategy and supports semiconductor capital expenditure cycles through 2026. This benefits the broader chip ecosystem including TSMC and Samsung foundries.

The AI infrastructure buildout is proving durable and capital-intensive, supporting semiconductor valuations despite macro uncertainty. However, this concentration of demand among a handful of hyperscalers creates geopolitical risk if export controls or supply chain disruptions emerge.